Literature DB >> 9524836

Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.

D L Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9524836     DOI： 10.1086/514585

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

Authors:  I Ginsburg
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

2.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Immunoglobulins in adult sepsis and septic shock.

Authors:  Susanne Toussaint; Herwig Gerlach
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

4.  Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literature.

Authors:  Marilyn Hassell; Peter Fagan; Phillip Carson; Bart J Currie
Journal:  BMC Infect Dis       Date:  2004-12-16       Impact factor: 3.090

5.  Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome.

Authors:  Wolfram Schummer; Claudia Schummer
Journal:  Infect Dis Obstet Gynecol       Date:  2002

Review 6.  Streptococcal toxic shock syndrome in the intensive care unit.

Authors:  Marylin Schmitz; Xavier Roux; Benedikt Huttner; Jérôme Pugin
Journal:  Ann Intensive Care       Date:  2018-09-17       Impact factor: 6.925
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.